High-Dose Subcutaneous Immunoglobulins for the Treatment of Severe Treatment-Resistant Polymyositis
Case Reports in Rheumatology
doi 10.1155/2014/458231
Full Text
Open PDFAbstract
Available in full text
Date
January 1, 2014
Authors
Publisher
Hindawi Limited